This can sometimes add to the dizziness or fatigue that might already occur with other medications, including Semaglutide
Our complete semaglutide vs tirzepatide comparison guide covers this in detail, but here are the key differences in weight loss outcomes: Average Weight Loss Comparison Semaglutide (STEP-1 trial, 68 weeks): Average weight loss: 14.9% 69.1% lost 10% or more 50.5% lost 15% or more Tirzepatide (SURMOUNT-1 trial, 72 weeks at 15 mg dose): Average weight loss: 22.5% 89% lost 10% or more 78% lost 15% or more Tirzepatide shows higher average weight loss in clinical trials, though both medications demonstrate significant effectiveness
Always use a calculator to verify your doses, especially with compounded formulations
This pattern of regain is consistent across trials of weight-loss medications in which participants were suddenly taken off the medication without a tapering schedule (where the dose is gradually reduced over time)
Small, consistent improvementsmore nutrient-dense foods, regular movement, better sleepcan make a measurable difference